knowledge -WSS

knowledge

author：hotspot 2025-09-03 12:09:42 - browse：927

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Researchers use wearables data and AI to predict preterm birth risk

focus

WSS

Medicaid, Medicare dual

FDA advisers vote against ALS treatment from BrainStorm

Clinical trials must include more disabled people

Covid vaccines: Private market messier than government rollout

Covid vaccines: Private market messier than government rollout

Listen: Who gets the credit for GLP

entertainment

knowledge

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Psychedelics group wrestles with new pharma identity

Would Medicare drug price negotiations stall in a shutdown?

Duchenne breakthrough therapy leaves behind pioneering families

STAT Virtual Event: How to Increase Diversity in Clinical Trials

How one medical school became remarkably diverse

Paxlovid should be available without a positive Covid test

New air purifier tech could be key to improving indoor air quality

Congress must give Medicare recipients genetic counseling access

hotspot

WHO recommends dropping component of many flu vaccines

Inequities make cancer less preventable for women: report

Baltimore teen accused of firing into crowd during block party mass shooting

Liz Cheney makes 1st public comment since Trump's election interference indictments

Covid vaccines: Private market messier than government rollout

Senator probes 340B programs at Cleveland Clinic, Bon Secours

focus

focus

hotspot

focus